Redwire Space
Canvas Category OEM : Aerospace
We are developing mission critical space solutions and high reliability components that are shaping the future of space exploration. With decades of flight heritage combined with an agile and innovative culture, Redwire is uniquely positioned to take on the critical space missions of today and tomorrow.
Assembly Line
🚀 Phase Four Series C First Closing
Phase Four, a leader in advanced in-space propulsion design and manufacturing, announced the first close of its Series C funding round, securing nearly 60% of the target raise with strong participation from new and existing investors. “This funding is a pivotal milestone for Phase Four as we scale to meet surging global demand for in-space propulsion from the government and private sector,” said Dr. Umair Siddiqui, Chief Technology Officer at Phase Four. The growth of Phase Four’s manufacturing capabilities addresses a critical supply-demand gap in the space industry. Phase Four is partnered with Redwire Space (RDW: NYSE) on the Valkyrie propulsion system, reflecting both companies’ view that the market for such thrusters will continue to be robust for the foreseeable future.
Redwire Announces Spaceflight Mission with Bristol Myers Squibb to Study Small Molecule Drug Compounds, Launching Additional Biopharma Investigations to Study Bone Disease Treatments in Space
Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced that it is launching an investigation to the International Space Station (ISS) in partnership with global leading biopharmaceutical company Bristol Myers Squibb (BMS) to study model small molecule compounds using Redwire’s pharmaceutical drug development platform (PIL-BOX). The research being conducted with BMS has the potential to enhance drug stability, streamline manufacturing processes, and improve efficiencies across various therapeutic areas, including oncology, immunology, and cardiovascular disease.
Additionally, Redwire will be launching a PIL-BOX investigation in partnership with pharmaceutical startup company ExesaLibero Pharma to study the novel drug ELP-004, which prevents excess bone removal associated with numerous diseases, including rheumatoid arthritis, multiple myeloma, and breast and prostate cancers. These newest spaceflight investigations further establish PIL-BOX as the premier space pharmaceutical research platform with 16 PIL-BOXes flown to date and 12 more set to launch on the next commercial resupply mission to the ISS.
A third PIL-BOX investigation launching to the ISS is being conducted in partnership with Butler University. Redwire and Butler University will seek to produce high-quality seed crystals in microgravity that could be used to produce pharmaceuticals on Earth. This is Butler University’s second PIL-BOX investigation.
Redwire’s First-of-Its-Kind Component Manufacturing Facility Successfully Completes Pathfinder Mission
Redwire’s MSTIC facility recently returned to Earth after successfully completing operations on the International Space Station (ISS) for a groundbreaking pathfinder mission to demonstrate advanced in-space manufacturing techniques. Developed in partnership with the ISS National Laboratory and NASA’s In Space Production Applications Flight Demonstrations program, MSTIC is an autonomous semiconductor manufacturing platform that was launched to the ISS onboard Northrop Grumman’s 20th cargo resupply services mission (NG-20) in February 2024.
MSTIC is being developed to 3D print semiconductor devices and thin-film integrated coatings to explore the beneficial effects of microgravity on these structures. Operations during the first mission demonstrated elements of processing by Physical Vapor Deposition (PVD) and Chemical Vapor Deposition (CVD). MSTIC includes a swappable production vacuum chamber, swappable gas cylinders, a crew serviceable computer, and high-voltage power supplies to produce a fully contained autonomous sputtering system.
🚀 2023 NASA Tipping Point Selections
NASA has selected 11 U.S. companies to develop technologies that will support long-term exploration on the Moon and in space under its sixth Tipping Point opportunity. The total expected NASA contribution to the partnerships is $150 million. Each company will contribute a minimum percentage, based on company size, of the total project cost. NASA’s Space Technology Mission Directorate (STMD) will issue milestone-based funded Space Act Agreements lasting for up to four years.